Medicine and Dentistry
Malignant Neoplasm
100%
Woman
68%
DNA Mismatch Repair
62%
Biological Marker
61%
Cells
57%
Xenotropic MuLV Related Virus
55%
Somatics
55%
Weight Loss
55%
Meta-Analysis
55%
Programmed Death 1 Ligand 1
55%
Systematic Review
55%
Chemotherapy
47%
Neoplasm
45%
Hazard Ratio
31%
Endometrial Cancer
28%
Protein
27%
Cancer
27%
Gene
27%
Metastatic Carcinoma
27%
Cell Line
27%
Bariatric Surgery
27%
Tissues
27%
Endometrium
27%
Obesity
27%
Hereditary Nonpolyposis Colorectal Cancer
22%
Human Immunodeficiency Virus
22%
Immunocompetent Cell
21%
Analysis
20%
Interleukin-6
20%
Serum
20%
Cell Type
17%
Marker
17%
Therapeutic Procedure
17%
Western Blot
16%
Overall Survival
15%
Cell Count
14%
Tumor Necrosis Factor
13%
Head and Neck Carcinoma
13%
Evolution
13%
Promoter Region
13%
Lesion
13%
Senescence
13%
Head and Neck Squamous Cell Carcinoma
13%
Development
13%
Stimulation
13%
Lymph Node Metastasis
13%
Low Calorie Diet
13%
Cell Density
13%
Microenvironment
13%
Diseases
13%
Biochemistry, Genetics and Molecular Biology
Protein
82%
DNA Mismatch Repair
55%
Autoantibodies
33%
Mutation
31%
Nested Gene
27%
Syncytin
27%
Survival
27%
TRIM33
22%
Poxviridae
22%
Species
22%
Senescence
13%
Promoter Region
13%
TP63
13%
Modulation
13%
MACF1
13%
RAC1
13%
Development
13%
Evolution
13%
Gene Mutation
13%
Messenger RNA
11%
CD8
11%
Cell Count
11%
TRIM21
11%
Virus
11%
Proteome
11%
Signal Transduction
11%
Molecular Mimicry
11%
Biological Phenomena and Functions Concerning the Entire Organism
11%
Interferon
11%
Autoantibody
11%
MLH1
7%
Immunocompetent Cell
7%
Cytotoxicity Assay
5%
Reverse Transcription Polymerase Chain Reaction
5%
Cell Proliferation
5%
Human Genome
5%
Aptitude
5%
Dose
5%
Gene Product
5%
Myeloid
5%
Kinetics
5%
Pharmacology, Toxicology and Pharmaceutical Science
Biological Marker
55%
Endometrium Cancer
55%
Recurrent Disease
55%
Programmed Death 1 Ligand 1
55%
Immune Checkpoint Inhibitor
55%
Malignant Neoplasm
55%
Survival
35%
Diseases
35%
Endogenous Retrovirus
27%
Prognosis
27%
Protein
27%
Death
27%
Neoplasm
15%
Clinical Trial
15%
Overall Survival
15%
Toxicity
11%
Messenger RNA
11%
Silver Nanoparticle
11%
Melanoma
7%
Side Effect
7%
Degenerative Disease
5%
Leukemia
5%
Acute Myeloid Leukemia
5%
Lymphatic Leukemia
5%
Multiple Sclerosis
5%
Antivirus Agent
5%
Antiinfective Agent
5%
Fanconi Anemia
5%